Cue Biopharma (CUE) Common Equity (2017 - 2026)
Cue Biopharma (CUE) posted Common Equity of $2.31 million for Q2 2026, down 87.3% from $18.16 million a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Common Equity (2017 - 2026) Analysis & Trends
At the end of FY2025, Cue Biopharma's Common Equity came in at $26.43 million, up 51.0% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of -19.6% (FY2020 to FY2025).
- In prior years, Cue Biopharma's Common Equity was $17.5 million in FY2024 (-52.8%), $37.09 million in FY2023 (-43.5%), $65.68 million in FY2022 (+0.3%) and $65.49 million in FY2021 (-17.0%).
- The Q2 2026 figure stands as the lowest quarterly Common Equity in data going back to Q4 2017.
- On a year-over-year basis, Common Equity increased in 1 of the last seven quarters, with an average decline of 38.8%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q4 2025, with growth of 51.0%; the weakest was Q2 2026, with a decline of 87.3%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.42 Bn | 1,106.00 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 617.98 Bn | 536.51 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 502.80 Bn | 475.92 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 368.67 Bn | 323.05 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.36 Bn | 262.35 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.17 Bn | 234.85 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.18 Bn | 192.58 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.11 Bn | 165.31 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 169.83 Bn | 116.48 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Cue Biopharma | 123.87 Mn | 33.14 Mn | - | 2.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.31 Mn |
| Dec 31, 2025 | 26.43 Mn |
| Sep 30, 2025 | 13.25 Mn |
| Jun 30, 2025 | 18.16 Mn |
| Mar 31, 2025 | 6.58 Mn |
| Dec 31, 2024 | 17.50 Mn |
| Sep 30, 2024 | 25.37 Mn |
| Jun 30, 2024 | 21.62 Mn |
| Mar 31, 2024 | 30.04 Mn |
| Dec 31, 2023 | 37.09 Mn |
| Sep 30, 2023 | 42.67 Mn |
| Jun 30, 2023 | 46.00 Mn |
| Mar 31, 2023 | 55.02 Mn |
| Dec 31, 2022 | 65.68 Mn |
| Sep 30, 2022 | 50.76 Mn |
| Jun 30, 2022 | 59.76 Mn |
| Mar 31, 2022 | 64.67 Mn |
| Dec 31, 2021 | 65.49 Mn |
| Sep 30, 2021 | 63.52 Mn |
| Jun 30, 2021 | 72.91 Mn |
API Access
Cue Biopharma Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();